Syneos Health, Inc. Class A Common Stock (SYNH)

SYNH was delisted on the 27th of September, 2023.

• Market cap: $4.46B
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Employees: 29,395